Exchange Capital Management’s Core Laboratories CLB Stock Holding History

Exchange Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$409K	Sell	35,489 -38,138	-52%	-$452K	0.06%	169
2025 Q1	$1.1M	Buy	73,627 +5,489	+8%	+$91.9K	0.18%	117
2024 Q4	$1.18M	Buy	68,138 +3,024	+5%	+$58.4K	0.19%	112
2024 Q3	$1.21M	Buy	65,114 +37,855	+139%	+$760K	0.19%	117
2024 Q2	$553K	Buy	+27,259	New	+$482K	0.09%	148
2020 Q1	–	Sell	-14,350	Closed	-$541K	–	142
2019 Q4	$541K	Buy	14,350 +8,510	+146%	+$382K	0.14%	116
2019 Q3	$272K	Buy	+5,840	New	+$272K	0.07%	137

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Exchange Capital Management's CLB Position: Q2 2025 in Review

Exchange Capital Management reduced its Core Laboratories (CLB) stake by 52% in Q2 2025, selling an estimated $452K and leaving 35,489 shares worth $409K. The position accounts for 0.06% of the portfolio, ranked #169.

Exchange Capital Management first reported a position in CLB in Q3 2019 and has held it in 7 quarters since. The position peaked at $1.21M in Q3 2024. 191 funds tracked by Wall St. Rank hold CLB as of Q2 2025.

Exchange Capital Management held 35,489 shares of Core Laboratories worth $409K as of Q2 2025.
Exchange Capital Management sold 38,138 Core Laboratories shares in Q2 2025, an estimated $452K.
Core Laboratories made up 0.06% of Exchange Capital Management's portfolio in Q2 2025, its #169 holding.
Exchange Capital Management first reported a position in Core Laboratories in Q3 2019 and has held it in 7 quarters since.
Exchange Capital Management's Core Laboratories position peaked at $1.21M in Q3 2024.
191 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2025.

Based on Exchange Capital Management's 13F filing for Q2 2025, filed 21 Jul 2025.